Profile image of Lorna Mills Dove, MD
Lorna Mills Dove, MD
Medical Director, Adult Liver Transplant - Center for Liver Disease and Transplantation, CUMC
Director of Clinical Hepatology

Call (212) 305-0914 for appointments.
1
1
1

About Lorna Mills Dove, MD:

Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Expertise:

Autoimmune Liver Disease
Cirrhosis
Gastroenterology
Hepatocellular Carcinoma
Liver Disease
Liver Disease in HIV
Liver Transplant
Non-Alcoholic Fatty Liver Disease
Transplant Hepatology
Viral Hepatitis

Honors:

2019 Member Columbia University Vagelos College of Physicians and Surgeons Academy of Clinical Excellence

2017 NYP Physician of the Year Award

2010 Ewig Clinical Scholar, Teaching Award Dept. of Medicine-Columbia University

2006 Nominee Columbia University Kimberg Faculty Teaching Award Nominee

2002 Nominee AMWA Gender Equity in Teaching Award

2001 UCSF Teaching Award for Outstanding Lecturer

1996 Robert Wood Johnson Minority Faculty Development Fellowship

1993 Alpha Omega Alpha Teaching Award, University of California at San Francisco

Appointments:

Professor of Medicine (in Surgery) at CUMC

Education:

Medical School: Columbia University College of Physicians and Surgeons
Residency: University of California-San Francisco Medical Center
Fellowship: University of California-San Francisco Medical Center

New Patients:

YES

Locations

Primary Locations:

CUIMC/Presbyterian Hospital and Vanderbilt Clinic

622 West 168th Street
Floor 14
New York, NY 10032

For new and current patient appointments, call:
(212) 305-0914
Fax:
(212) 305-4343

Other Locations:

ColumbiaDoctors - 1375 Washington Avenue

1375 Washington Ave, Suite 101
Albany, NY 12206

For new and current patient appointments, call:
212-305-0914

ColumbiaDoctors - 300 Frank Burr Blvd

300 Frank W Burr Blvd
Suite 130
Teaneck, NJ 07666

ColumbiaDoctors - 1985 Crompond Road

1985 Crompond Road
Suite Area E
Cortlandt Manor, NY 10567

Insurances:

Please contact the doctor's office directly to verify that your particular insurance is accepted.

AETNA [NY Signature, Student Health, Aetna Signature Administrators, NYP Employee Plan]
Affinity Health Plan [Medicaid Managed Care]
AmeriHealth of New Jersey [POS - New Jersey Services, EPO - New Jersey Services, HMO - New Jersey Services, PPO - New Jersey Services, POS - New Jersey Services]
Amerigroup of New Jersey [New Jersey Services (Medicaid Managed Care)]
CIGNA [PPO, HMO, POS, EPO, Medicare Managed Care, Great West (National), POS, POS]
Capital District Physician Health Plan (CDPHP) [PPO, HMO, Medicaid Managed Care, EPO]
Emblem/GHI [Medicare Managed Care, PPO]
Emblem/HIP [Medicare Managed Care, Vytra, Essential Plan, HMO, PPO, POS, EPO, Select Care (Exchange), ConnectiCare, ConnectiCare, PPO]
Empire Blue Cross Blue Shield HealthPlus [Medicaid Managed Care, Essential Plan, Child/Family Health Plus]
Empire Blue Cross/Blue Shield [Medicare Managed Care, EPO]
Fidelis Care [Medicare Managed Care, Medicaid Managed Care]
Healthfirst [Child/Family Health Plus, Medicare Managed Care, Leaf (Exchange), Medicaid Managed Care]
Horizon Blue Cross Blue Shield [EPO - New Jersey Services]
Local 1199 [Local 1199, Local 1199]
MVP Health Care [Medicaid Managed Care, Child/Family Health Plus, Essential Plan, Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
MagnaCare (National) [MagnaCare, MagnaCare]
Medicare [Railroad, Traditional Medicare]
Multiplan [Multiplan, Multiplan]
QualCare [HMO - New Jersey Services, PPO - New Jersey Services, HMO - New Jersey Services, PPO - New Jersey Services, POS - New Jersey Services]
Quality Health Management [Quality Health Management]
RiverSpring [Special Needs]
TRICARE [TRICARE, TRICARE]
UnitedHealthcare [Columbia University Employee Plan, POS, PPO, HMO, Compass (Exchange), Empire Plan, Medicaid (Community Plan), Oxford Liberty, Oxford HMO, Oxford Freedom, HMO]
VNSNY CHOICE [Special Needs, SelectHealth]
WellCare [Medicare Managed Care, New Jersey Services (Medicaid Managed Care), New Jersey Services (Medicare Managed Care)]
World Trade Center Health Plan [World Trade Center Health Plan]

Publications:

Original Peer Reviewed ArticlesVerna E, Shetty K, Lukose T, Terry N, Mentore K, Olsen, SK, Fox AN, Dove, LM, Brown RS. High Post-Transplant Virological Response in Hepatitis C Virus Infected Patients Treated with Pretransplant Protease Inhibitor-based Triple Therapy. Liver International. 35(2):510-,2015, Feb.

Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP, Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC. Combination of Liver biopsy with MELD-XI Scores for Post-Transplant Outcome Prediction in Patients with Advanced Heart Failure and Suspected Liver Dysfunction. J Heart Lung Transplant. 34(7): 873-82. 2015, Jul.

Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove, L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS JR. Phase I Trial of Sorafenib following Liver Transplantation in Patients with High-Risk Hepatocellular carcinoma. Liver Cancer. 4(2): 115-25.2013 March.

Hsu CC, Goyal A, Iuga A, Krishnamurthy S, Lee V, Verna EC, Wang S, Chen FN, Rodriguez, R, Emond J, Berk P, Lefkowitch, J, Dove L, Brown RS Jr. Siegel AB. Elevated CA19-9 Is Associated with Increaed Mortality IN a Prospective Cohort Of Hepatocellular Carcinoma Patients. Clin Transl Gastreonterology.6: e74. 2015 Feb.

Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, Fox AN, Dove LM, Brown RS. High Post-Transplant Virological Response in Hepatitis C Virus Infected Patients Treated with PreTransplant Protease Inhibitor-Based Triple Therapy. Liver International 35(2):510-7,2015 Feb.

Siegel AB, Conner K, Wang S, Jacobson JS, Hershman DL, Hidalgo R, Verna EC, Halazun K, Brubaker W, Zaretsky J, Moniodis A, Delgado-Cruzata L, Dove L, Emond J, Kato T, Brown RS Jr., Neugut A. Smoking and Hepatocellular Carcinoma Mortality. Exp Ther Med. 2012Jan; 3(1): 124-128.

Siegel A, Lim EA. Wang S. Brubaker W, Rodriguez RD. Goyal A. Jacobson J. Hershman DL, Verna EC, Zaretsky, J, Halazun K, Dove L, Brown, RS Jr. Neugut A, Kato T, Remotti H, Coppleson Y, Emond JC. Diabetes, Body Mass Index and Outcomes in Hepatocellular Carcinoma Patients undergoing Liver Transplantation. Transplantation. 94(5): 539-42, 2012 Sep.

Terrault N, Roland ME, Schiano T, Dove L, Wong MT, et al. Outcomes of Liver Transplant Recipients with Hepatitis C and Human Immunodeficiency Virus Coinfection. Liver Transplantation. 18(6): 716-726, 2012, Jun.

Talal A, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein et al. Randomized Trial Comparing Dose Reduction and Growth Factor Supplementiaotn for Management of Hematological Side Effects in HIV/Hepatitis C virus Patients Receiving Pegylated-Interferon and Ribavirin. Jo Acquir Immune Defic Syndr. 58 (3): 261-8, 2011 Nov. 1

Subramanian A. Sulkowski M. Barin B. Stablein D. Curry M. Nissen N. Dove L. Roland M. Florman S. Blumberg E. Stosor V. Jayaweera DT. Huprikar S. Fung J. Pruett T. Stock P. Ragni M. MELD Score is an Important Predictor of Pre-transplantation Mortality in HIV-Infected Liver Transplant Candidates. Gastroenterology. 138(1): 159-64, 2010 Jan.

Coffin CS. Stock PG. Dove LM. Berg CL. Nissen NN. Curry MP. Ragni M. Regenstein FG. Sherman KE. Roland ME. Terrault NA. Virologic and Clinical Outcomes of Hepatitis B virus Infection in HIV-HBV Coinfected Transplant Recipients. American Journal of Transplantation. 10(5): 1268-75, 2010 May.

Siegel AB. Wang S. Jacobson JS. Hershman DL. Lim EA. Yu J. Ferrante L. Devaraj KM. Remotti H. Scrudato S. Halazun K. Emond J. Dove L. Brown RS Jr. Neugut AI. Obesity and Microvascular Invasion in Hepatocellular Carcinoma. Cancer Investigation. 28(10): 1063-9, 2010 Dec.